Biology subjects

Chen, C.-S.

Publications and source records attributed to Chen, C.-S..

5 recordsLinked to original sources

bioRxiv2025

Sperm-specific fertility factors SMZ-1/2 promote FB-MO biogenesis and MSP filament assembly in C. elegans

In nematode sperm, motility is powered by polymerization of major sperm protein (MSP) into filaments assembled from a specialized organelle (FB-MO), but how filament formation begins is unclear. We identify two sperm-specific PDZ proteins, SMZ-1 and SMZ-2 (SMZ-1/2), that initiate MSP loading into pre-formed membranous organelles in Caenorhabditis elegans. SMZ-1/2 were expressed specifically in spermatogenic germ cells, colocalized with developing FB-MOs from diplotene through spermatid formation, and were redundant for fertility. Loss of SMZ-1/2 abolished MSP filaments, left MOs MSP-negative and morphologically immature, and caused primary spermatocyte arrest. Electron microscopy showed fewer, smaller FB-MOs lacking crystalline FBs, consistent with a defect in assembly initiation rather than late polymerization. SMZ-1/2 cytoplasmic structures were absent in spe-6 casein kinase mutants, placing SMZ-1/2 within a SPE-6-dependent initiation module. These findings identify SMZ-1/2 as PDZ scaffold proteins that initiate MSP assembly and couple kinase signaling to FB-MO biogenesis during nematode spermatogenesis.

genetics↗

bioRxiv2025

Phosphatidylinositol Transfer Protein-1 Integrates Insulin/IGF-1 and TOR Signaling to Negatively Regulate Lifespan and Healthspan in Caenorhabditis elegans

BackgroundPhosphatidylinositol transfer protein-1 (pitp-1) is involved in phosphoinositide turnover. The role of pitp-1 in promoting healthy longevity remains unknown. Our previous work showed that the phosphoinositide turnover genes dagl-1 and dgk-5 regulates lifespan, as overexpression of dagl-1 or knockdown of dgk-5 prolongs lifespan and enhances oxidative stress resistance through TOR signaling. As pitp-1 is a key component of this pathway, we investigated its role in lifespan regulation and the underlying mechanisms, aiming to clarify whether it represents a critical regulator of healthy longevity and how it coordinates conserved signaling pathways to regulate aging. MethodsC. elegans mutants, RNAi-mediated knockdown, and transgenic overexpression were applied to assess lifespan, motility, stress resistance. Temporal and tissue-specific RNAi were applied to identify the critical time window and tissue for pitp-1-mediated lifespan regulation. TOR signaling was measured by phosphorylated S6 kinase and puromycin incorporation, and transcriptomic analysis identified affected pathways. Resultspitp-1 negatively regulates lifespan and healthspan in Caenorhabditis elegans. Genetic deletion or RNAi-mediated knockdown of pitp-1 extends lifespan, attenuates age-related motility decline, and increases oxidative stress resistance. Temporal and spatial analyses reveal that suppression of pitp-1 in neurons during early adulthood is sufficient to promote healthy longevity. Mechanistically, these beneficial effects upon pitp-1 reduction are mediated by suppressing TOR signaling. Conversely, pitp-1 overexpression shortens lifespan and impairs healthspan via TOR activation. Moreover, pitp-1 is transcriptionally repressed by DAF-16 downstream of insulin/IGF-1 signaling (IIS), and contributes to IIS-mediated lifespan extension. ConclusionThese findings identify pitp-1 as a novel regulator of healthy aging that integrates IIS and TOR pathways, providing new insights into conserved mechanisms for promoting healthy longevity.

genetics↗

bioRxiv2023

Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitis

The pathogenesis of antibodies in severe alcoholic hepatitis (SAH) remains unknown. We sought to determine if there was antibody deposition in SAH livers and whether antibodies extracted from SAH livers were cross-reactive against both bacterial antigens and human proteins. We analyzed immunoglobulins (Ig) in explanted livers from SAH patients (n=45) undergoing liver transplantation and tissue from corresponding healthy donors (HD, n=10) and found massive deposition of IgG and IgA isotype antibodies associated with complement fragment C3d and C4d staining in ballooned hepatocytes in SAH livers. Ig extracted from SAH livers, but not patient serum exhibited hepatocyte killing efficacy in an antibody-dependent cell-mediated cytotoxicity (ADCC) assay. Employing human proteome arrays, we profiled the antibodies extracted from explanted SAH, alcoholic cirrhosis (AC), nonalcoholic steatohepatitis (NASH), primary biliary cholangitis (PBC), autoimmune hepatitis (AIH), hepatitis B virus (HBV), hepatitis C virus (HCV) and HD livers and found that antibodies of IgG and IgA isotypes were highly accumulated in SAH and recognized a unique set of human proteins as autoantigens. The use of an E. coli K12 proteome array revealed the presence of unique anti-E. coli antibodies in SAH, AC or PBC livers. Further, both Ig and E. coli captured Ig from SAH livers recognized common autoantigens enriched in several cellular components including cytosol and cytoplasm (IgG and IgA), nucleus, mitochondrion and focal adhesion (IgG). Except IgM from PBC livers, no common autoantigen was recognized by Ig and E. coli captured Ig from AC, HBV, HCV, NASH or AIH suggesting no cross-reacting anti-E. coli autoantibodies. The presence of cross-reacting anti-bacterial IgG and IgA autoantibodies in the liver may participate in the pathogenesis of SAH.

pathology↗

bioRxiv2019

Pathogenicity of urinary tract infection Escherichia coli in Caenorhabditis elegans

Uropathogenic Escherichia coli (UPEC) is a major bacterial pathogen that causes urinary tract infections (UTIs). Several virulence factors (VFs) in the bacteria have been associated with the pathogenicity. The mouse is an available UTI model for studying the pathogenicity; however, Caenorhabditis elegans represents as an alternative surrogate host for studying UPEC with the capacity for high-throughput analysis. Therefore, we established a simple assay for a UPEC infection model with C. elegans for large-scale screening. An E. coli culture to be tested and synchronized C. elegans were mixed in 96-well plates, and the pathogenicity was determined by comparison of the turbidity before and after incubation. A total of 133 clinically isolated E. coli strains, which included UTI-associated and fecal isolates, were applied to demonstrate the liquid pathogenicity assay. The E. coli isolates associated with UTIs showed higher pathogenicity in C. elegans than the fecal isolates, suggesting that the simple assay with C. elegans is useful as a UPEC infectious model. From the screening, VFs involved with iron acquisition (chuA, fyuA, and irp2) were significantly associated with high pathogenicity. C. elegans is a heme auxotroph, and iron homeostasis also serves innate immunity in C. elegans. We then evaluated whether the VFs in UPEC were involved in the pathogenicity. Mutants of E. coli UTI89 with defective iron acquisition systems were applied to a solid killing assay with C. elegans. As a result, the survival rate of C. elegans fed with the mutants significantly increased compared to when fed with the parent strain. To our knowledge, this is the first report of the involvement of iron acquisition in the pathogenicity of UPEC in a C. elegans model.

microbiology↗

bioRxiv2017

Combined Androgen Administration and HDAC Inhibition in Experimental Cancer Cachexia

PurposeThe common colon-26 mouse (C-26) model of experimental cachexia mimics recent late stage clinical failures of anabolic anti-cachexia therapy, and does not respond to the anabolic selective androgen receptor modulator (SARM) GTx-024. Based on the demonstrated anti-cachectic efficacy of the histone deacetylase inhibitor (HDACi) AR-42 in this model, we hypothesized that combined SARM/AR-42 would provide improved anti-cachectic efficacy.\n\nDesignIn the C-26 model, we determined a reduced efficacious dose of AR-42 which was combined with anabolic SARM therapy and evaluated for anti-cachectic efficacy. The effects of treatment and tumor burden on anabolic and catabolic signaling occurring in skeletal muscle were characterized using muscle performance parameters and RNA-seq.\n\nResultsAnabolic anti-cachexia therapy with diverse androgens had no impact on cachectic outcomes in the C-26 model. A reduced dose of the HDACi AR-42 alone provided limited anti-cachectic benefits, but when combined with the SARM GTx-024, significantly improved bodyweight (p<0.0001), hind limb muscle mass (p<0.05), and voluntary grip strength (p<0.0001) versus tumor-bearing controls. Reduced-dose AR-42 treatment suppressed the IL-6/GP130/STAT3 signaling axis without significantly impacting circulating cytokine levels. GTx-024-mediated {beta}-catenin target gene regulation was apparent in cachectic mice only when combined with AR-42.\n\nConclusionsCachectic signaling in the C-26 model is comprised of catabolic signaling insensitive to anabolic GTx-024 therapy and a blockade of GTx-024-mediated anabolic signaling. AR-42 treatment mitigates catabolic gene activation and restores anabolic responsiveness to GTx-024. Combining GTx-024, a clinically established anabolic therapy, with a low dose of AR-42, a clinically evaluated HDACi, represents a promising approach to improve anabolic response in cachectic patient populations.

cancer biology↗